Wariishi S, Miyahara K, Toda K, Ogoshi S, Doi Y, Ohnishi S, Mitsui Y, Yui Y, Kawai C, Shizuta Y
Department of Medical Chemistry, Kochi Medical School, Japan.
Biochem Biophys Res Commun. 1995 Nov 13;216(2):729-35. doi: 10.1006/bbrc.1995.2682.
Endothelial nitric oxide synthase (eNOS) is an important oxygenase which catalyzes the conversion of L-arginine to L-citrulline to form nitric oxide (NO), a potent important factor for vasodilation and inhibition of platelet aggregation. We have analyzed characteristics of the promoter region of the human eNOS gene using the transient expression in human endothelial cells of CAT constructs with a series of 5'-deletion mutants. The 5'-flanking region between -116 and -98, which contains a putative consensus sequence for binding of transcription factor Sp1, is essential to direct a basal promoter activity. Gel mobility shift analysis involving anti-Sp1 antibody and competitor DNAs disrupted at the binding site for Sp1 reveals that Sp1 or its closely related protein(s) binds to the consensus sequence located between -104 and -96. These results indicate that the Sp1 site is essential for a core promoter activity of the human eNOS gene.